New coronavirus infection COVID-19 and women's reproductive health. Facts and assumptions
https://doi.org/10.25789/YMJ.2022.77.25
Abstract
Data on possible ways of influence of SARS-CoV-2 and COVID-19 virus on female reproductive system and already recorded negative consequences are presented in the literature review. The recommendations on pregnancy planning and features of the use of hormonal contraception methods are outlined as well as approaches to specific prevention of new coronavirus infection from the point of view of safety and preservation of reproductive health of women during the COVID-19 pandemic.
About the Authors
L. S. Ishchenko
South Ural State Medical University MH RF, obstetrician-gynecologist Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
Ishchenko Lyudmila Stanislavovna – PhD in Medical Sciences, Associate Professor of the Department of obstetrics and gynecology
E. E. Voropaeva
South Ural State Medical University of the MF RF, Deputy Chief Physician for Obstetrics and Gynecology, Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
Voropaeva Ekaterina Evgenievna – Grand PhD in Medical Sciences, Associate Professor, Professor of the Department of pathological anatomy and forensic medicine
E. A. Kazachkova
South Ural State Medical University MH RF
Russian Federation
Russian Federation
Kazachkova Ella Alekseevna – Grand PhD in Medical Sciences, Professor, Professor of the Department of Obstetrics and Gynecology
Yu. V. Khaidukova
South Ural State Medical University MH RF, head of the 2nd Obstetric Department of the Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
Khaidukova Yulia Vladimirovna – Postgraduate at Department of Obstetrics and Gynecology
Chelyabinsk
E. L. Kazachkova
South Ural State Medical University MH RF
Russian Federation
Russian Federation
Kazachkova Ella Alekseevna – Grand PhD in Medical Sciences, Professor, Professor of the Department of Obstetrics and Gynecology
References
1. Obstetric, perinatal outcomes and the state of the afterbirth in women with a new coronavirus infection covid-19, manifested during fullterm pregnancy / L.S. Ishchenko [et al.]. South-Ural medical journal. 2021; (3): 35-46.
2. Pregnancy and childbirth in women with the manifestation of a new coronavirus infection Covid-19 in the first trimester of gestation / Yu.V. Khaydukova [et al.]. South-Ural medical journal. 2021; (3): 47-59.
3. Gam-COVID-Vac (Sputnik V) vaccine has no adverse effect on ovarian reserve in reproductive-age women / N.V. Dolgushina [et al.]. Obstetrics and gynecology. 2021; 7: 81-86. DOI:10.18565/aig. 2021.7.81-86
4. Miscarriage (spontaneous abortion). Clinical recommendations (ID:670) [Electronic resource]. 2021. URL: http://chelsma.ru/files/misc/vykidysh_samoproizvolnyjabort_.pdf (date of access : 08.02.2022)
5. Clinical course, maternal and perinatal outcomes of 2019 novel coronavirus infectious disease (COVID-19) in pregnant women in Siberia and Far East / T.E. Belokrinitskaya [et al.]. Obstetrics and gynecology. 2021; (2): 48-54. DOI: 10.18565/aig.202L2.48-54
6. Melekhova M.A., Boklagova Y.V. Changes in menstruation after COVID-19 and vaccination. Obstetrics and gynecology. 2021; (12): 146-152. DOI: 10.18565/aig.2021.12.146-152
7. Methodological recommendations "Organization of medical care for pregnant women, women in labor, women in labor and newborns with a new coronavirus infection Covid-19". Version 5 (approved by the Ministry of Health of the Russian Federation 28.12.2021). URL: https:// sudact.ru/law/metodicheskie-rekomendatsii-organizatsiia-okazaniia-meditsinskoi-pomoshchi-beremennym/metodicheskie-rekomendatsii/(date of access: 09.02.2022).
8. Coronavirus pandemic [Electronic resource]. URL: https://www.interfax.ru/russia/813516 (date of access: 09.02.2022).
9. Parfenova Y.A., Shibelgut N.M., Artymuk N.V. The impact of new coronavirus infection COVID-19 on women's reproductive health. Mother and child in Kuzbass. 2021; 3(86): 36-40. DOI: 10.24412/2686-7338-2021-3-36-40
10. Sexual and reproductive health. Newsletter [Electronic resource] / World Health Organization, Regional Office for Europe. URL: https://www.euro.who.int/__data/assets/pdf_file/0006/364947/sexual-reproductive-health-rus.pdf (date of access: 09.02.2022).
11. Stopcoronavirus.rf [Electronic resource]. URL: https://xn--80aesfpebagmfblc0a.xn--p1ai/ (date of access: 09.02.2022).
12. Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients / C. Song [et al.] // Biol Reprod. 2020; 103(1): 4-6. DOI: 10.1093/biolre/ioaa050.
13. Analysis of ovarian in jury associated with COVID-19 disease in reproductiveaged women in Wuhan, China: An Observational Study / T. Ding [et al.] // Front. Med. (Lausanne). 2021; 19(8): 635255. DOI:10.3389/fmed.2021.635255.
14. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age / K. Li [et al.] //Reprod Biomed Online. 2021; 42(1): 260-267. DOI: 10.1016/j.rbmo.2020.09.020
15. Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary / F.M. Reis [et al.] // Fertil Steril. 2011; 95(1): 176-81. DOI: 10.1016/j.fertnstert.2010.06.060.
16. Assisted reproduction and COVID-19. A statement from ESHRE for phase 1 - Guidance on fertility services during pandemic [Electronic resource]. 2 April 2020 (last revision 17 April). URL: https://www.eshre.eu/Press-Room/ESHRE-News/2020 (date of access: 09.02.2022).
17. Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination: A U.S. Cohort / A. Edelman [et al.] // Obstet Gynecol. 2022; Jan 5. DOI: 10.1097/AOG.0000000000004695.
18. Clinical characteristics andoutcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis / M. Jafari [et al.] // Rev Med Virol. 2021; Jan 2: e2208. DOI: 10.1002/rmv.2208
19. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues / K.E. Stanley [et al.] //Fertility and sterility. 2020; 114(1): 33-43. DOI: 10.1016/j.fertnstert.2020.05.001.
20. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients / S. Cosma [et al.] // Am J Obstet Gynecol. 2021; 224(4): 391. e1-391.e7. DOI: 10.1016/j.ajog.2020.10.005
21. Coronavirus disease 2019 in pregnant women: a report based on 116 cases / J. Yan [et al.] //Am J Obstet Gynecol. 2020; 223(1): 111.e1-111.e14. DOI: 10.1016/j.ajog.2020.04.014
22. Demir O., Sal H., Comba C. Triangle of COVID, anxiety and menstrual cycle // J Obstet Gynaecol. 2021; 41(8): 1257-1261. DOI:10.1080/01443615.2021.1907562.
23. Diriba K., Awulachew E., Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysisь // Eur J Med Res. 2020; 25(1): 39. DOI: 10.1186/s40001-020-00439-w.
24. Does mRNA SARS-CoV-2 vaccine influence patients’ performance during IVF-ET cycle? / R. Orvieto [et al.] // Reprod Biol Endocrinol. 2 021; 19(1): 69. D OI: 10.1186/ s12958-021-00757-6.
25. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany / A. Bäuerle [et al.] // J Public Health (Oxf). 2020; 42(4): 672-678. DOI: 10.1093/pubmed/fdaa106
26. Investigating the risk of maternal-fetal transmission of SARS-CoV-2 in early pregnancy / F. Halici-Ozturk
27. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study / A.B. Docherty [et al.] // BMJ 2020; 369: m1985. DOI: 10.1136/bmj.m1985.
28. Li K., Nowak R.A. The role of basigin in reproduction //Reproduction. 2020; 159(2): R97-R109. DOI: 10.1530/REP-19-0268
29. Orchitis: a complication of severe acute respiratory syndrome (SARS) / J. Xu [et al.] // Biol Reprod. 2006; 74(2): 410-416. DOI: 10.1095/biolreprod.105.044776.
30. Phelan N., Behan L.A., Owens L. The Impact of the COVID-19 Pandemic on Women’s Reproductive Health // Front Endocrinol (Lausanne). 2021; 12: 642755. DOI: 10.3389/fendo. 2021.642755.
31. Potential risks of SARS-CoV-2 infection on reproductive health / R. Li [et al.] // Reprod Biomed Online. 2020; 41(1): 89-95. DOI: 10.1016/j.rbmo.2020.04.018.
32. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. / J.M. Cénat [et al.] // Psychiatry Res. 2021; 295: 113599. DOI: 10.1016/j.psychres.2020.113599
33. Public Health England. COVID-19: investigation and initial clinical management of possible cases. 2020. [Electronic resource]. URL: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases (date of access: 11.02.2022)
34. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein [Electronic resource] / K . Wang [et al.]. URL: https://www.biorxiv.org/content/10.1101/2020.03.14.98834 5v1 (date of access: 11.02.2022)
35. Sengupta P., Dutta S. Does SARSCoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress // Eur J Contracept Reprod Health Care. 2 020; 2 5(5):405-406. D OI: 1 0.1080/13625187.2020.1787376
36. The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium / J. Vaz-Silva [et al.] // Reproductive Sciences. 2009; 16(3): 247-256. DOI: 10.1177/1933719108327593
37. The impact of COVID-19-related mental health issues on menstrual cycle characteristics of female healthcare providers / T. Takmaz [et al.] // J Obstet Gynaecol Res. 2021; 47(9): 3241-3249. DOI: 10.1111/jog.14900
38. World Health Organization. Coronavirus disease (COVID-19): Contraception and family planning [Electronic resource] . URL: www. who.int/news-room/q-a-detail/coronavirus-disease-covid-19-contraception-andfamily-planning 2020 (date of access: 11.02.2022) h ttps:// www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-contraception-and-family-planning
39. Younger people are more vulnerable to stress, anxiety and depression during COVID-19 pandemic: A global cross-sectional survey / P. Varma [et al.] // Prog Neuropsychopharmacol Biol Psychiatry. 2021; 109: 110236. DOI: 10.1016/j.pnpbp.2020.110236
Review
For citations:
Ishchenko L.S., Voropaeva E.E., Kazachkova E.A., Khaidukova Yu.V., Kazachkova E.L. New coronavirus infection COVID-19 and women's reproductive health. Facts and assumptions. Yakut Medical Journal. 2022;(2):96-101. https://doi.org/10.25789/YMJ.2022.77.25
Views:
38
Email this article 